CMS 347v7: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

Measure: Percentage of the following patients - all considered at high risk of cardiovascular events - who were prescribed or were on statin therapy during the measurement period:

  • All patients who were previously diagnosed with or currently have a diagnosis of clinical atherosclerotic cardiovascular disease (ASCVD), including an ASCVD procedure; OR

  • Patients aged 20 to 75 years who have ever had a low-density lipoprotein cholesterol (LDL-C) level ≥ 190 mg/dL or were previously diagnosed with or currently have an active diagnosis of familial hypercholesterolemia; OR

  • Patients aged 40-75 years with a diagnosis of diabetes; OR

  • Patients aged 40 to 75 with a 10-year ASCVD risk score of ≥ 20 percent

Measure Type High Priority Measure Scoring
Process No A higher percentage indicates better quality
Denominator

Denominator 1: All patients who were previously diagnosed with or currently have a diagnosis of clinical ASCVD, including an ASCVD procedure

Denominator 2: Patients aged 20 to 75 years at the beginning of the measurement period who have ever had a laboratory result of LDL-C ≥ 190 mg/dL or were previously diagnosed with or currently have an active diagnosis of familial hypercholesterolemia

Denominator 3: Patients aged 40-75 years at the beginning of the measurement period with Type 1 or Type 2 diabetes

Denominator 4: Patients aged 40-75 at the beginning of the measurement period with a 10-year ASCVD risk score (i.e., 2013 ACC/AHA ASCVD Risk Estimator or the ACC Risk Estimator Plus) of ≥ 20 percent during the measurement period.

Numerator Patients who are actively using or who receive an order (prescription) for statin therapy at any time during the measurement period
Denominator Exceptions
  • Patients with statin-associated muscle symptoms or an allergy to statin medication

  • Patients who are receiving palliative or hospice care

  • Patients with active liver disease or hepatic disease or insufficiency

  • Patients with end-stage renal disease (ESRD)

  • Patients with documentation of a medical reason for not being prescribed statin therapy

Denominator Exclusions
  • Patients who are breastfeeding at any time during the measurement period

  • Patients who have a diagnosis of rhabdomyolysis at any time during the measurement period

 

Return to 2024 eCQMs

 

Didn't find the answer you were looking for?

Contact Sevocity Support 24/7 at 877‑777‑2298 or support@sevocity.com